Bacil Pharma Limited (BACPHAR.BO)
INR 60.12
(-1.99%)
INR 60.12
(-1.99%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -569.32 Thousand INR | -29.4% |
| 2022 | -991.16 Thousand INR | -48.74% |
| 2021 | -38.56 Million INR | -67.76% |
| 2020 | -2.34 Million INR | -54.24% |
| 2019 | -3.07 Million INR | 76.51% |
| 2018 | -3.34 Million INR | 37.09% |
| 2017 | -37.39 Million INR | -146.86% |
| 2016 | 12.48 Thousand INR | -22.07% |
| 2015 | -661.98 Thousand INR | -83.03% |
| 2014 | -279.33 Thousand INR | 71.01% |
| 2013 | -1.03 Million INR | -401.41% |
| 2012 | -207.17 Thousand INR | -172.64% |
| 2011 | 437.33 Thousand INR | 196.71% |
| 2010 | -452.21 Thousand INR | -24.59% |
| 2009 | -362.96 Thousand INR | 0.56% |
| 2008 | -365 Thousand INR | -2907.69% |
| 2007 | 13 Thousand INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -444 Thousand INR | -11.28% |
| 2024 Q2 | -725 Thousand INR | -63.29% |
| 2023 Q1 | -297 Thousand INR | -99.9% |
| 2023 Q4 | -611 Thousand INR | -7.57% |
| 2023 FY | - INR | -29.4% |
| 2023 Q2 | -399 Thousand INR | -34.34% |
| 2023 Q3 | -568 Thousand INR | -42.36% |
| 2022 Q1 | -422 Thousand INR | 98.85% |
| 2022 FY | - INR | -48.74% |
| 2022 Q2 | -417 Thousand INR | 1.18% |
| 2022 Q3 | -459 Thousand INR | -10.07% |
| 2022 Q4 | -148.57 Thousand INR | 67.63% |
| 2021 Q3 | -368 Thousand INR | 60.68% |
| 2021 Q1 | -290 Thousand INR | 86.27% |
| 2021 Q2 | -936 Thousand INR | -222.76% |
| 2021 Q4 | -36.85 Million INR | -9914.92% |
| 2021 FY | - INR | -67.76% |
| 2020 FY | - INR | -54.24% |
| 2020 Q1 | -216 Thousand INR | -119.08% |
| 2020 Q2 | -300 Thousand INR | -38.89% |
| 2020 Q3 | -663 Thousand INR | -121.0% |
| 2020 Q4 | -2.11 Million INR | -218.55% |
| 2019 Q3 | -2.66 Million INR | -248.17% |
| 2019 Q2 | -764 Thousand INR | -11.05% |
| 2019 Q4 | 1.13 Million INR | 142.56% |
| 2019 FY | - INR | 76.51% |
| 2019 Q1 | -688 Thousand INR | -140.05% |
| 2018 Q1 | -1.15 Million INR | -18.43% |
| 2018 Q3 | -1.03 Million INR | 8.83% |
| 2018 Q2 | -1.13 Million INR | 1.57% |
| 2018 Q4 | 1.71 Million INR | 266.47% |
| 2018 FY | - INR | 37.09% |
| 2017 Q3 | -787 Thousand INR | 12.26% |
| 2017 Q1 | -522 Thousand INR | -225.78% |
| 2017 FY | - INR | -146.86% |
| 2017 Q4 | -971 Thousand INR | -23.38% |
| 2017 Q2 | -897 Thousand INR | -71.84% |
| 2016 Q1 | -445 Thousand INR | -1111.36% |
| 2016 Q2 | 87 Thousand INR | 119.55% |
| 2016 FY | - INR | -22.07% |
| 2016 Q4 | 415 Thousand INR | 1002.17% |
| 2016 Q3 | -46 Thousand INR | -152.87% |
| 2015 Q4 | 44 Thousand INR | 116.36% |
| 2015 FY | - INR | -83.03% |
| 2015 Q2 | -153 Thousand INR | 46.32% |
| 2015 Q1 | -285 Thousand INR | 57.92% |
| 2015 Q3 | -269 Thousand INR | -75.82% |
| 2014 Q4 | -677.31 Thousand INR | -2609.28% |
| 2014 FY | - INR | 71.01% |
| 2014 Q2 | -36 Thousand INR | 79.07% |
| 2014 Q1 | -172 Thousand INR | 84.72% |
| 2014 Q3 | -25 Thousand INR | 30.56% |
| 2013 Q4 | -1.12 Million INR | -746.54% |
| 2013 FY | - INR | -401.41% |
| 2013 Q2 | -57 Thousand INR | -21.28% |
| 2013 Q3 | -133 Thousand INR | -133.33% |
| 2013 Q1 | -47 Thousand INR | 93.51% |
| 2012 Q2 | -375 Thousand INR | -132.0% |
| 2012 Q1 | 1.17 Million INR | 153.5% |
| 2012 Q3 | -391 Thousand INR | -4.27% |
| 2012 Q4 | -723.68 Thousand INR | -85.09% |
| 2012 FY | - INR | -172.64% |
| 2011 Q4 | 462.33 Thousand INR | 320.3% |
| 2011 FY | - INR | 196.71% |
| 2011 Q3 | 110 Thousand INR | 0.0% |
| 2010 FY | - INR | -24.59% |
| 2009 FY | - INR | 0.56% |
| 2008 Q4 | -113 Thousand INR | 0.0% |
| 2008 FY | - INR | -2907.69% |
| 2007 Q4 | -9000.00 INR | 0.0% |
| 2007 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | 189.13% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | 104.915% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | 100.64% |
| Vasundhara Rasayans Limited | 84.22 Million INR | 100.676% |
| Sunil Healthcare Limited | 93.07 Million INR | 100.612% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | 103.447% |
| MedPlus Health Services Limited | 3.94 Billion INR | 100.014% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | 99.623% |
| Patidar Buildcon Limited | -5.52 Million INR | 89.697% |
| Roopa Industries Limited | 55.7 Million INR | 101.022% |
| Smruthi Organics Limited | 120.31 Million INR | 100.473% |
| Trident Lifeline Limited | 102.69 Million INR | 100.554% |
| PANJON LTD. | 4.08 Million INR | 113.923% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | 99.538% |
| Gujarat Terce Laboratories Limited | 15.87 Million INR | 103.586% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | 97.012% |
| Anuh Pharma Limited | 878.5 Million INR | 100.065% |
| Crestchem Limited | 30.33 Million INR | 101.877% |
| Emmessar Biotech & Nutrition Limited | -10.81 Million INR | 94.737% |
| Sandu Pharmaceuticals Limited | 27.19 Million INR | 102.094% |
| Tyche Industries Limited | 128.2 Million INR | 100.444% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | 100.146% |
| Trimurthi Limited | -2.47 Million INR | 77.03% |
| Shukra Pharmaceuticals Limited | 216.59 Million INR | 100.263% |
| Norris Medicines Limited | -1.78 Million INR | 68.09% |
| Zenlabs Ethica Limited | 27.09 Million INR | 102.101% |
| Vikram Thermo (India) Limited | 386.92 Million INR | 100.147% |
| ANG Lifesciences India Limited | 90.66 Million INR | 100.628% |
| Parmax Pharma Limited | 22.93 Million INR | 102.482% |
| Veerhealth Care Limited | 15.99 Million INR | 103.559% |
| Deccan Health Care Limited | 37.5 Million INR | 101.518% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | 100.224% |
| Makers Laboratories Limited | 25.81 Million INR | 102.206% |
| Lactose (India) Limited | 201.22 Million INR | 100.283% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | 99.408% |
| Zenith Healthcare Limited | 4.98 Million INR | 111.414% |
| Sanjivani Paranteral Limited. | 87.58 Million INR | 100.65% |
| PRAVEG LIMITED | 321.43 Million INR | 100.177% |
| Denis Chem Lab Limited | 224.84 Million INR | 100.253% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | 100.093% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | 100.151% |
| Colinz Laboratories Limited | 5.42 Million INR | 110.489% |
| Godavari Drugs Limited | 134.62 Million INR | 100.423% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | -40.227% |
| Zenotech Laboratories Limited | 172.64 Million INR | 100.33% |
| Panchsheel Organics Limited | 189.36 Million INR | 100.301% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | 100.127% |
| Vivanza Biosciences Limited | 11.2 Million INR | 105.081% |
| Phaarmasia Limited | -1.58 Million INR | 64.013% |
| Sastasundar Ventures Limited | -203.51 Million INR | 99.72% |
| Medi-Caps Limited | 4.77 Million INR | 111.933% |
| DECIPHER LABS LIMITED | -2.72 Million INR | 79.069% |
| Gujarat Themis Biosyn Limited | 830.99 Million INR | 100.069% |
| Ambalal Sarabhai Enterprises Limited | 170.57 Million INR | 100.334% |
| Mercury Laboratories Limited | 101.18 Million INR | 100.563% |
| Gennex Laboratories Limited | 219.35 Million INR | 100.26% |
| BDH Industries Limited | 124.27 Million INR | 100.458% |
| Coral Laboratories Limited | 227.07 Million INR | 100.251% |
| Concord Drugs Limited | 40.52 Million INR | 101.405% |
| Bharat Parenterals Limited | 265.74 Million INR | 100.214% |
| Beryl Drugs Limited | 26.63 Million INR | 102.137% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | 98.242% |
| Evoq Remedies Limited | 6.18 Million INR | 109.2% |
| Add-Shop E-Retail Limited | 82.61 Million INR | 100.689% |
| Transchem Limited | 56.61 Million INR | 101.006% |
| Ishita Drugs and Industries Limited | 11.88 Million INR | 104.789% |
| Parnax Lab Limited | 243.59 Million INR | 100.234% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | 101.271% |
| Kerala Ayurveda Limited | 70.78 Million INR | 100.804% |
| Cian Healthcare Limited | 122.56 Million INR | 100.464% |
| Trinity League India Limited | -26.25 Million INR | 97.831% |
| Syschem (India) Limited | 70.4 Million INR | 100.809% |
| KOBO BIOTECH LIMITED | -8.57 Million INR | 93.359% |
| Natural Capsules Limited | 219.9 Million INR | 100.259% |
| Auro Laboratories Limited | 121.73 Million INR | 100.468% |